(NOVN) Novartis - Performance 7.6% in 12m

NOVN performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.

Performance Rating 51.30%
#14 in Peer-Group
Rel. Strength 53.09%
#3569 in Stock-Universe
Total Return 12m 7.58%
#62 in Peer-Group
Total Return 5y 54.83%
#31 in Peer-Group
P/E Value
P/E Trailing 18.7
P/E Forward 14.1
High / Low CHF
52 Week High 99.78 CHF
52 Week Low 82.96 CHF
Sentiment Value
VRO Trend Strength +-100 79.29
Buy/Sell Signal +-5 0.19
Support / Resistance Levels
Support
Resistance
12m Total Return: NOVN (7.6%) vs XLV (-5.1%)
Total Return of Novartis versus its related sector ETF XLV
5y Drawdown (Underwater) Chart
5 Year Drawdown / Underwater Chart for (NOVN) Novartis - Performance 7.6% in 12m

Top Performer in Pharmaceuticals

Short Term Performance

Symbol 1w 1m 3m
NOVN -0.42% 7.55% -1.46%
PHAT 20.5% 206% 120%
VTYX 0.0% 112% 81.6%
ALTS 3.27% 64.1% 127%

Long Term Performance

Symbol 6m 12m 5y
NOVN 14.4% 7.58% 54.8%
ALTS 172% 335% 234%
VRNA 116% 453% 1,673%
BGM 57.0% 276% -72.2%

Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating

Symbol 1m 12m 5y P/E P/E Forward PEG EPS Stability EPS CAGR
CORT NASDAQ
Corcept Therapeutics
-4.5% 145% 360% 61.3 55.3 0.61 23.7% -5.15%
LLY NYSE
Eli Lilly
12% -6.78% 514% 66.1 37 1.24 58.2% 18.9%
NVS NYSE
Novartis
10.1% 17.9% 81.6% 18.5 14 1.37 8.70% 9.2%
NOVN SW
Novartis
7.55% 7.58% 54.8% 18.7 14.1 1.38 9.80% 11.2%
SFZN SW
Siegfried Holding
-0.63% 2.28% 140% 26.1 25 1.48 77.8% 77.6%
GSK NYSE
GlaxoSmithKline
10% 4.92% 57.7% 19.9 9.2 0.4 -25.2% 3.11%
AZN NASDAQ
AstraZeneca
9.51% -4.27% 58.6% 28.9 15.9 0.96 52.7% 22.3%
IPN PA
Ipsen
2.14% -13% 54.2% 24.4 10.3 0.74 -6.40% -6.33%

Performance Comparison: NOVN vs XLV vs S&P 500

XLV (Health Care Sector SPDR ETF) is the Sector Benchmark for NOVN
Total Return (including Dividends) NOVN XLV S&P 500
1 Month 7.55% 4.35% 1.11%
3 Months -1.46% -6.89% 5.58%
12 Months 7.58% -5.08% 10.51%
5 Years 54.83% 50.53% 109.12%

Trend Score (consistency of price movement) NOVN XLV S&P 500
1 Month 94.5% 65.8% 69.9%
3 Months -21.3% -72% 69.3%
12 Months -4.8% -62.2% 43.2%
5 Years 92% 88.5% 84.1%

Relative Strength (compared with Indexes) Rank in Peer Group vs. XLV vs. S&P 500
1 Month #74 3.07% 6.37%
3 Month #94 5.83% -6.67%
12 Month #61 13.34% -2.65%
5 Years #34 2.86% -25.96%

FAQs

Does Novartis (NOVN) outperform the market?

Yes, over the last 12 months NOVN made 7.58%, while its related Sector, the Health Care Sector SPDR (XLV) made -5.08%. Over the last 3 months NOVN made -1.46%, while XLV made -6.89%.

Performance Comparison NOVN vs Indeces and Sectors

Above 0 means better perfomance compared to Symbol in this Timeframe

NOVN vs. Indices

Symbol 1w 1m 6m 12m
US S&P 500 SPY 0% 6.4% 15.4% -3%
US NASDAQ 100 QQQ 0.3% 6.1% 16.1% -2%
German DAX 40 DAX 2.2% 8.3% -1% -22%
Shanghai Shenzhen CSI 300 CSI 300 0.3% 8.5% 13.5% -4%
Hongkong Hang Seng HSI -0.5% 2.5% -3.7% -20%
India NIFTY 50 INDA 1.8% 8.9% 16.4% 9%
Brasil Bovespa EWZ -2.3% 7.1% -4.8% -2%

NOVN vs. Sectors

Symbol 1w 1m 6m 12m
Communication Services XLC 0.4% 6.1% 12.6% -15%
Consumer Discretionary XLY 0.6% 9.4% 25.2% -10%
Consumer Staples XLP 0.3% 7.8% 13.9% 1%
Energy XLE -5.8% 4.6% 11.8% 4%
Financial XLF 1.6% 10.1% 12.5% -16%
Health Care XLV -1.9% 3.2% 15.8% 13%
Industrial XLI 1.1% 7.2% 9.8% -11%
Materials XLB 0.7% 6.2% 14.6% 8%
Real Estate XLRE -0.5% 6.6% 14.4% -6%
Technology XLK -0.3% 5.5% 15% 3%
Utilities XLU -1.4% 7% 7% -14%
Aerospace & Defense XAR 1% 1.8% -1.6% -35%
Biotech XBI 0.4% -0.2% 26.1% 15%
Homebuilder XHB 1.6% 12.6% 30.8% 17%
Retail XRT 4% 7.7% 23.3% 7%

NOVN vs. Commodities

Symbol 1w 1m 6m 12m
Oil USO -11.8% -11.1% 5.51% 4%
Natural Gas UNG 0.8% 10.2% -2.9% 22%
Gold GLD -3.6% 1.4% -14.8% -40%
Silver SLV 0.8% -3.8% -4.2% -15%
Copper CPER 2.6% 5.8% 0.5% -1%

NOVN vs. Bonds

Symbol 1w 1m 6m 12m
iShares 20+ Years Bond TLT -1.5% 6.9% 16.8% 12%
iShares High Yield Corp. Bond HYG -0.5% 7% 11.7% -2%